NASDAQ:CODX

Company-diagnostics Stock News

etoro logo Buy CODX
*Your capital is at risk
$5.17
-1.05 (-16.88%)
At Close: Jun 03, 2026
Gainers Embark Technology, Inc. (NASDAQ: EMBK) jumped 84.8% to close at $1.07 on Friday after the company reported better-than-expected Q2 EPS results. Twin Vee Powercats Co. (NASDAQ: VEEE) shares cl
Gainers Twin Vee Powercats Co. (NASDAQ: VEEE) shares jumped 90% to $7.60 after the company said Q2 sales results were up year over year. Unity Biotechnology, Inc. (NYSE: UBX) jumped 70% to $1.4492 af
Upgrades Mizuho upgraded the previous rating for Safehold Inc (NYSE:SAFE) from Neutral to Buy. For the second quarter, Safehold had an EPS of $0.37, compared to year-ago quarter EPS of $0.28. At the
Olo Inc. (NYSE: OLO) shares fell 31.7% to $8.87 in pre-market trading after the company reported Q2 results and issued FY22 guidance below consensus estimates. CS Disco, Inc. (NYSE: LAW) fell 27.8% t
U.S. index futures are pointing to a moderately positive open on Wall Street on Friday following the lackluster close in the previous session. At the time of going to press, the Dow futures, the S&P f
Gainers Neptune Wellness Solutions Inc. (NASDAQ: NEPT) shares rose 66.9% to $2.37 in pre-market trading. Neptune Wellness Solutions recently announced voluntary delisting from Toronto Stock Exchange
Pre-open movers U.S. stock futures traded higher in early pre-market trade on Friday after closing mixed in the previous session. Investors are awaiting earnings results from Broadridge Financial Sol
With US stock futures trading higher this morning on Friday, some of the stocks that may grab investor focus today are as follows: Wall Street expects Broadridge Financial Solutions, Inc. (NYSE: BR)

CoDiagnostics, Inc. (CODX) Reports Q2 Loss, Lags Revenue Estimates

09:35pm, Thursday, 11'th Aug 2022 Zacks Investment Research
CoDiagnostics, Inc. (CODX) delivered earnings and revenue surprises of -166.67% and 75.50%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Co-Diagnostics, Inc. (NASDAQ:CODX ) Q2 2022 Earnings Conference Call August 11, 2022 4:30 PM ET Company Participants Andrew Benson - Head of Investor Relations Dwight Egan - Chairman, President and Ch
CoDiagnostics, Inc. (CODX) delivered earnings and revenue surprises of -166.67% and 75.50%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Co-Diagnostics Inc (NASDAQ:CODX) ended its second quarter of 2022 with a cash balance of US$96 million to help it progress development of its Co-Dx PCR Home testing platform for infectious disease

Why Shares of Co-Diagnostics Stock Fell 10% on Tuesday

09:09pm, Tuesday, 09'th Aug 2022 The Motley Fool
The stock dropped two days before reporting second-quarter earnings.
The stock dropped two days before reporting second-quarter earnings.

CoDiagnostics, Inc. (CODX) Surges 5.8%: Is This an Indication of Further Gains?

01:35pm, Tuesday, 26'th Jul 2022 Zacks Investment Research
CoDiagnostics, Inc. (CODX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE